Overview
Orthopaedic surgery has revolutionized the treatment of musculoskeletal conditions, offering relief to millions worldwide. However, the rise of degenerative diseases such as osteoarthritis and spinal stenosis poses a significant challenge. According to a study published in the Journal of Orthopaedic Research, approximately 30% of patients who undergo orthopaedic surgery will develop degenerative diseases within 10 years. Furthermore, a report by the World Health Organization (WHO) estimates that degenerative diseases will affect over 1.7 billion people globally by 2025, with a significant economic burden of over $300 billion. The debate surrounding the efficacy of orthopaedic surgery in preventing or slowing the progression of degenerative diseases is ongoing, with some arguing that surgical intervention can exacerbate the condition, while others claim it can provide significant relief. As the global population ages, the demand for orthopaedic surgery will continue to rise, making it essential to understand the complex relationship between surgical intervention and degenerative diseases. Researchers like Dr. David F. Hamilton and Dr. Gordon H. Guyatt are working to develop new treatments and therapies that can address the root causes of degenerative diseases, rather than just the symptoms. For instance, a recent study published in the journal Nature Medicine found that a novel gene therapy can reduce the progression of osteoarthritis by up to 50% in animal models.